vs
Side-by-side financial comparison of Clearfield, Inc. (CLFD) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($57.3M vs $34.3M, roughly 1.7× Clearfield, Inc.). Clearfield, Inc. runs the higher net margin — -1.8% vs -83.0%, a 81.2% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (36.9% vs -3.2%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (48.5% CAGR vs -3.5%).
Clearfield, Inc. is a company headquartered in Minneapolis, Minnesota. The company produces fiber optic products.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
CLFD vs RYTM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $34.3M | $57.3M |
| Net Profit | $-614.0K | $-47.5M |
| Gross Margin | 33.2% | 91.6% |
| Operating Margin | -5.3% | -82.2% |
| Net Margin | -1.8% | -83.0% |
| Revenue YoY | -3.2% | 36.9% |
| Net Profit YoY | 67.8% | -9.6% |
| EPS (diluted) | $-0.04 | $-0.73 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $34.3M | $57.3M | ||
| Q3 25 | $23.4M | $51.3M | ||
| Q2 25 | $49.9M | $48.5M | ||
| Q1 25 | $47.2M | $32.7M | ||
| Q4 24 | $29.7M | $41.8M | ||
| Q3 24 | $5.6M | $33.3M | ||
| Q2 24 | $48.8M | $29.1M | ||
| Q1 24 | $36.9M | $26.0M |
| Q4 25 | $-614.0K | $-47.5M | ||
| Q3 25 | $-9.1M | $-52.9M | ||
| Q2 25 | $1.6M | $-46.6M | ||
| Q1 25 | $1.3M | $-49.5M | ||
| Q4 24 | $-1.9M | $-43.3M | ||
| Q3 24 | — | $-43.6M | ||
| Q2 24 | $-447.0K | $-32.3M | ||
| Q1 24 | $-5.9M | $-141.4M |
| Q4 25 | 33.2% | 91.6% | ||
| Q3 25 | 53.2% | 89.3% | ||
| Q2 25 | 30.5% | 88.6% | ||
| Q1 25 | 30.1% | 88.8% | ||
| Q4 24 | 29.2% | 90.9% | ||
| Q3 24 | — | 88.5% | ||
| Q2 24 | 21.9% | 89.9% | ||
| Q1 24 | 7.7% | 89.2% |
| Q4 25 | -5.3% | -82.2% | ||
| Q3 25 | 10.3% | -102.6% | ||
| Q2 25 | 3.0% | -93.4% | ||
| Q1 25 | 0.6% | -143.7% | ||
| Q4 24 | -6.9% | -98.6% | ||
| Q3 24 | — | -132.0% | ||
| Q2 24 | -4.7% | -139.2% | ||
| Q1 24 | -26.4% | -538.7% |
| Q4 25 | -1.8% | -83.0% | ||
| Q3 25 | -38.8% | -103.1% | ||
| Q2 25 | 3.2% | -96.1% | ||
| Q1 25 | 2.8% | -151.4% | ||
| Q4 24 | -6.4% | -103.6% | ||
| Q3 24 | — | -131.2% | ||
| Q2 24 | -0.9% | -110.9% | ||
| Q1 24 | -16.0% | -544.4% |
| Q4 25 | $-0.04 | $-0.73 | ||
| Q3 25 | $-0.65 | $-0.82 | ||
| Q2 25 | $0.11 | $-0.75 | ||
| Q1 25 | $0.09 | $-0.81 | ||
| Q4 24 | $-0.13 | $-0.71 | ||
| Q3 24 | — | $-0.73 | ||
| Q2 24 | $-0.04 | $-0.55 | ||
| Q1 24 | $-0.40 | $-2.35 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $96.4M | $388.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $249.7M | $139.1M |
| Total Assets | $268.1M | $480.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $96.4M | $388.9M | ||
| Q3 25 | $106.0M | $416.1M | ||
| Q2 25 | $117.2M | $291.0M | ||
| Q1 25 | $112.0M | $314.5M | ||
| Q4 24 | $113.0M | $320.6M | ||
| Q3 24 | $129.0M | $298.4M | ||
| Q2 24 | $123.8M | $319.1M | ||
| Q1 24 | $142.9M | $201.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $2.2M | — | ||
| Q2 24 | $2.1M | — | ||
| Q1 24 | — | — |
| Q4 25 | $249.7M | $139.1M | ||
| Q3 25 | $256.2M | $148.8M | ||
| Q2 25 | $264.5M | $-11.9M | ||
| Q1 25 | $265.9M | $18.9M | ||
| Q4 24 | $267.4M | $21.7M | ||
| Q3 24 | $275.8M | $11.2M | ||
| Q2 24 | $274.6M | $39.3M | ||
| Q1 24 | $279.2M | $61.6M |
| Q4 25 | $268.1M | $480.2M | ||
| Q3 25 | $306.2M | $506.9M | ||
| Q2 25 | $314.7M | $372.7M | ||
| Q1 25 | $310.9M | $386.7M | ||
| Q4 24 | $303.2M | $392.3M | ||
| Q3 24 | $315.3M | $363.6M | ||
| Q2 24 | $318.1M | $381.8M | ||
| Q1 24 | $315.4M | $258.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.01× | — | ||
| Q2 24 | 0.01× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.4M | $-25.4M |
| Free Cash FlowOCF − Capex | $-2.4M | — |
| FCF MarginFCF / Revenue | -7.1% | — |
| Capex IntensityCapex / Revenue | 2.9% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.4M | $-25.4M | ||
| Q3 25 | — | $-26.6M | ||
| Q2 25 | $7.9M | $-23.3M | ||
| Q1 25 | $3.0M | $-40.4M | ||
| Q4 24 | $7.2M | $-18.8M | ||
| Q3 24 | $22.2M | $-25.2M | ||
| Q2 24 | $4.0M | $-29.1M | ||
| Q1 24 | $-5.7M | $-40.7M |
| Q4 25 | $-2.4M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $7.5M | — | ||
| Q1 25 | $654.0K | — | ||
| Q4 24 | $5.1M | — | ||
| Q3 24 | $18.2M | — | ||
| Q2 24 | $2.8M | — | ||
| Q1 24 | $-7.7M | — |
| Q4 25 | -7.1% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 15.1% | — | ||
| Q1 25 | 1.4% | — | ||
| Q4 24 | 17.1% | — | ||
| Q3 24 | 323.0% | — | ||
| Q2 24 | 5.8% | — | ||
| Q1 24 | -20.8% | — |
| Q4 25 | 2.9% | — | ||
| Q3 25 | 2.0% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 5.1% | — | ||
| Q4 24 | 7.0% | — | ||
| Q3 24 | 71.4% | — | ||
| Q2 24 | 2.5% | — | ||
| Q1 24 | 5.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.93× | — | ||
| Q1 25 | 2.30× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
